Gamma-aminobutyric acid (GABA) receptor agonist drugs are a type of sedative drug that mimics the activity of the neurotransmitter receptors known as gamma-aminobutyric acid (GABA) receptors found in the mammalian brain. They are used to treat a variety of CNS disorders.

The latest research study released by Market IntelliX evaluates market size and forecasts of Gamma-aminobutyric Acid (GABA) Receptor Agonist in Global, including the following market information:

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gamma-aminobutyric Acid (GABA) Receptor Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gamma-aminobutyric Acid (GABA) Receptor Agonist include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin and Johnson & Johnson Services, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Gamma-aminobutyric Acid (GABA) Receptor Agonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, by Type, 2021 (%)

Oral

Parenteral

Intrathecal

Others

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, by Application, 2021 (%)

Hospitals

Specialty Clinics

Others

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gamma-aminobutyric Acid (GABA) Receptor Agonist revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gamma-aminobutyric Acid (GABA) Receptor Agonist revenues share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Sanofi

Mylan N.V.

Teva Pharmaceutical Industries

Novartis

Aytu BioScience

Dr. Reddy’s Laboratories

Endo Pharmaceuticals

Lupin

Johnson & Johnson Services

Lannett

Sun Pharmaceutical Industries

Cipla

Aurobindo Pharma

Zydus Cadila

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Overall Market Size

2.1 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size: 2021 VS 2028

2.2 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market

3.2 Top Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies Ranked by Revenue

3.3 Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Companies

3.4 Top 3 and Top 5 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies in Global Market, by Revenue in 2021

3.5 Global Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Type

3.6 Tier 1, Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market

3.6.1 List of Global Tier 1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies

3.6.2 List of Global Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size Markets, 2021 & 2028

4.1.2 Oral

4.1.3 Parenteral

4.1.4 Intrathecal

4.1.5 Others

4.2 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts

4.2.1 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022

4.2.2 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028

4.2.3 By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2021 & 2028

5.1.2 Hospitals

5.1.3 Specialty Clinics

5.1.4 Others

5.2 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts

5.2.1 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022

5.2.2 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028

5.2.3 By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2021 & 2028

6.2 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue & Forecasts

6.2.1 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2022

6.2.2 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2023-2028

6.2.3 By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028

6.3.2 US Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.3.3 Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.3.4 Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028

6.4.2 Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.3 France Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.4 U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.5 Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.6 Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.7 Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.4.8 Benelux Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028

6.5.2 China Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.5.3 Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.5.4 South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.5.5 Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.5.6 India Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028

6.6.2 Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.6.3 Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028

6.7.2 Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.7.3 Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.7.4 Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

6.7.5 UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size, 2017-2028

7 Players Profiles

7.1 Sanofi

7.1.1 Sanofi Corporate Summary

7.1.2 Sanofi Business Overview

7.1.3 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.1.4 Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.1.5 Sanofi Key News

7.2 Mylan N.V.

7.2.1 Mylan N.V. Corporate Summary

7.2.2 Mylan N.V. Business Overview

7.2.3 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.2.4 Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.2.5 Mylan N.V. Key News

7.3 Teva Pharmaceutical Industries

7.3.1 Teva Pharmaceutical Industries Corporate Summary

7.3.2 Teva Pharmaceutical Industries Business Overview

7.3.3 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.3.4 Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.3.5 Teva Pharmaceutical Industries Key News

7.4 Novartis

7.4.1 Novartis Corporate Summary

7.4.2 Novartis Business Overview

7.4.3 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.4.4 Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.4.5 Novartis Key News

7.5 Aytu BioScience

7.5.1 Aytu BioScience Corporate Summary

7.5.2 Aytu BioScience Business Overview

7.5.3 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.5.4 Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.5.5 Aytu BioScience Key News

7.6 Dr. Reddy’s Laboratories

7.6.1 Dr. Reddy’s Laboratories Corporate Summary

7.6.2 Dr. Reddy’s Laboratories Business Overview

7.6.3 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.6.4 Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.6.5 Dr. Reddy’s Laboratories Key News

7.7 Endo Pharmaceuticals

7.7.1 Endo Pharmaceuticals Corporate Summary

7.7.2 Endo Pharmaceuticals Business Overview

7.7.3 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.7.4 Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.7.5 Endo Pharmaceuticals Key News

7.8 Lupin

7.8.1 Lupin Corporate Summary

7.8.2 Lupin Business Overview

7.8.3 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.8.4 Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.8.5 Lupin Key News

7.9 Johnson & Johnson Services

7.9.1 Johnson & Johnson Services Corporate Summary

7.9.2 Johnson & Johnson Services Business Overview

7.9.3 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.9.4 Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.9.5 Johnson & Johnson Services Key News

7.10 Lannett

7.10.1 Lannett Corporate Summary

7.10.2 Lannett Business Overview

7.10.3 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.10.4 Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.10.5 Lannett Key News

7.11 Sun Pharmaceutical Industries

7.11.1 Sun Pharmaceutical Industries Corporate Summary

7.11.2 Sun Pharmaceutical Industries Business Overview

7.11.3 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.11.4 Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.11.5 Sun Pharmaceutical Industries Key News

7.12 Cipla

7.12.1 Cipla Corporate Summary

7.12.2 Cipla Business Overview

7.12.3 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.12.4 Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.12.5 Cipla Key News

7.13 Aurobindo Pharma

7.13.1 Aurobindo Pharma Corporate Summary

7.13.2 Aurobindo Pharma Business Overview

7.13.3 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.13.4 Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.13.5 Aurobindo Pharma Key News

7.14 Zydus Cadila

7.14.1 Zydus Cadila Corporate Summary

7.14.2 Zydus Cadila Business Overview

7.14.3 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Major Product Offerings

7.14.4 Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global Market (2017-2022)

7.14.5 Zydus Cadila Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Tables

Table 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunities & Trends in Global Market

Table 2. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Drivers in Global Market

Table 3. Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Restraints in Global Market

Table 4. Key Players of Gamma-aminobutyric Acid (GABA) Receptor Agonist in Global Market

Table 5. Top Gamma-aminobutyric Acid (GABA) Receptor Agonist Players in Global Market, Ranking by Revenue (2021)

Table 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue by Companies, (US$, Mn), 2017-2022

Table 7. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Share by Companies, 2017-2022

Table 8. Global Companies Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Type

Table 9. List of Global Tier 1 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Gamma-aminobutyric Acid (GABA) Receptor Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2017-2022

Table 13. By Type - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2023-2028

Table 14. By Application – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028

Table 15. By Application - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2017-2022

Table 16. By Application - Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in Global (US$, Mn), 2023-2028

Table 17. By Region – Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2021 & 2028

Table 18. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), 2017-2022

Table 19. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), 2023-2028

Table 20. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022

Table 21. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028

Table 22. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022

Table 23. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028

Table 24. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022

Table 25. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028

Table 26. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022

Table 27. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028

Table 28. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2022

Table 29. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2023-2028

Table 30. Sanofi Corporate Summary

Table 31. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 32. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 33. Mylan N.V. Corporate Summary

Table 34. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 35. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 36. Teva Pharmaceutical Industries Corporate Summary

Table 37. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 38. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 39. Novartis Corporate Summary

Table 40. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 41. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 42. Aytu BioScience Corporate Summary

Table 43. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 44. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 45. Dr. Reddy’s Laboratories Corporate Summary

Table 46. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 47. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 48. Endo Pharmaceuticals Corporate Summary

Table 49. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 50. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 51. Lupin Corporate Summary

Table 52. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 53. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 54. Johnson & Johnson Services Corporate Summary

Table 55. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 56. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 57. Lannett Corporate Summary

Table 58. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 59. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 60. Sun Pharmaceutical Industries Corporate Summary

Table 61. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 62. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 63. Cipla Corporate Summary

Table 64. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 65. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 66. Aurobindo Pharma Corporate Summary

Table 67. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 68. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

Table 69. Zydus Cadila Corporate Summary

Table 70. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Product Offerings

Table 71. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue (US$, Mn), (2017-2022)

List of Figures

Figure 1. Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Type in 2021

Figure 2. Gamma-aminobutyric Acid (GABA) Receptor Agonist Segment by Application in 2021

Figure 3. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, 2017-2028 (US$, Mn)

Figure 7. The Top 3 and 5 Players Market Share by Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue in 2021

Figure 8. By Type - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 9. By Application - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 10. By Region - Global Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 11. By Country - North America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 12. US Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 13. Canada Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 14. Mexico Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 15. By Country - Europe Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 16. Germany Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 17. France Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 18. U.K. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 19. Italy Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 20. Russia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 21. Nordic Countries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 22. Benelux Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 23. By Region - Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 24. China Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 25. Japan Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 26. South Korea Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 27. Southeast Asia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 28. India Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 29. By Country - South America Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 30. Brazil Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 31. Argentina Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 32. By Country - Middle East & Africa Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Market Share, 2017-2028

Figure 33. Turkey Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 34. Israel Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 35. Saudi Arabia Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 36. UAE Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue, (US$, Mn), 2017-2028

Figure 37. Sanofi Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 38. Mylan N.V. Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 39. Teva Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 40. Novartis Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 41. Aytu BioScience Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 42. Dr. Reddy’s Laboratories Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 43. Endo Pharmaceuticals Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 44. Lupin Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 45. Johnson & Johnson Services Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 46. Lannett Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 47. Sun Pharmaceutical Industries Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 48. Cipla Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 49. Aurobindo Pharma Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 50. Zydus Cadila Gamma-aminobutyric Acid (GABA) Receptor Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)